Changing the game in mental health treatment.
Wise Therapeutics uses breakthrough neuroscientific research to improve mental health through casual, accessible mobile games.
Changing the game
in mental health treatment.
Wise Therapeutics uses breakthrough neuroscientific research to improve mental health through casual, accessible mobile games.
Science First
With a decade’s worth of NIH-backed clinical R&D, Wise is the first to apply mobile game-based neurocognitive training techniques to therapeutic areas such as anxiety, distress and addiction.
Wise’s digital therapeutics have resulted in:
Reduction in self-reported anxiety
Reduction in stress hormone cortisol
Reduction in cognitive signs of anxiety
Reduction in alcohol cravings
Research Collaborators
Research Sponsors
Featured News and Media
Wise Therapeutics’ Science-Backed Games Help People Fight Anxiety
Co-founders Raj Amin and Dr. Tracy Dennis-Tiwary want to prescribe mobile games which could lower the barriers to mental health care for millions.
Wise Therapeutics' Game-Based App Reduces Anxiety in Multiple Sclerosis Patients, NYU Study Finds
A newly published clinical study from Wise and NYU Langone Health found that adolescent and young adult MS patients who used Wise’s Personal Zen app for one month reported reductions of at least 20% in their anxiety levels. That broke down to an average drop of just over 20% in those aged 12 to 17 and nearly 40% in study participants aged 18 to 23.
Wise Therapeutics and Soterix Medical Jointly Announce Positive Results of Study Combining Gamified Digital Therapeutics with Neurostimulation Device
Wise Therapeutics (Wise), a developer of game-based digital therapeutics including Personal Zen, and Soterix Medical, a leading manufacturer of wearable tDCS medical devices, jointly announced the results of their collaborative study, published in Frontiers in Neuroergonomics.
Investors
Contact Us